Meanwhile, in the ACh-CaCl2-induced AF model of db/db mice, the incidence and duration of AF were decreased after Zbtb16-KD, Txnip-KD, or Mito-TEMPO treatment (Fig. 7C–E). The gene discussed is ZBTB16; the disease is atrial fibrillation.